Now showing items 1-1 of 1

    • Caro Vega, Yanink; Belaunzaran Zamudio, Pablo F.; Crabtree Ramírez, Brenda E.; Shepherd, Bryan E.; Grinsztejn, Beatriz; Wolff Reyes, Marcelo; Pape, Jean W.; Padgett, Denis; Gotuzzo, Eduardo; McGowan, Catherine C.; Sierra Madero, Juan G. (Oxford University Press, 2018)
      Background. Efavirenz (EFV) and boosted protease inhibitors (bPIs) are still the preferred options for firstline antiretroviral regimens (firstline ART) in Latin America and have comparable short-term efficacy. We assessed ...